x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- LetterRemove Letter filter
- COVID-19Remove COVID-19 filter
- 2020 - 2022Remove 2020 - 2022 filter
Author
- Finsterer, Josef4
- Scorza, Fulvio A3
- Ahmed, Sabeena1
- Alied, Marcel1
- Chang, Chia-Ning1
- Chang, Jessica R1
- Chen, Chi-Sheng1
- Chen, Shyi-Jou1
- Conceicao, Edwin Philip1
- Delanghe, Joris R1
- Durón, Reyna M1
- Fiorini, Ana C1
- Gupta, Deepak1
- Hu, Chih-Fen1
- Huy, Nguyen Tien1
- Khan, Wasif Ali1
- Khan, Zeeshan Ali1
- Li, Joy1
- Lippi, Giuseppe1
- Makram, Abdelrahman M1
- Matovu, Daniel1
- O'Fee, John R1
- Plebani, Mario1
- Ramírez, Céleo1
- Scorza, Carla A1
Coronavirus (COVID-19) Collection
13 Results
- Letter to the EditorOpen Access
Workup of cerebral involvement in patients with COVID-19 – authors’ reply
International Journal of Infectious DiseasesIn Press Journal Pre-ProofPublished online: October 26, 2022- Chi-Sheng Chen
- Chia-Ning Chang
- Shyi-Jou Chen
- Chih-Fen Hu
- Hung-Sheng Shang
Cited in Scopus: 0We thank Scorza et al. for their comments on our article (Chen et al., 2022) discussing the new S protein mutation of SARS-CoV-2 and its potential effects on immune regulation, associated with the apparent increase in the incidence of severe neurological symptoms in Taiwanese pediatric patients. - LetterOpen Access
Workup for cerebral involvement in COVID-19 requires cerebral imaging, electroencephalography, and cerebrospinal fluid studies
International Journal of Infectious DiseasesVol. 125p285–286Published online: October 20, 2022- Carla A. Scorza
- Josef Finsterer
- Fulvio A. Scorza
- Antonio-Carlos G. de Almeida
Cited in Scopus: 0We read with interest the article by Chen et al. (2022) concerning five pediatric patients with severe neurological complications of acute SARS-CoV-2 infection. It was concluded that a new mutation in the spike protein of the Omicron BA.2.3.7 variant may be responsible for the sudden increase in neurological complications of COVID-19 (Chen et al., 2022). The study is appealing but raises concerns. - Letter to the EditorOpen Access
Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
International Journal of Infectious DiseasesVol. 122p443Published online: June 24, 2022- Josef Finsterer
- Fulvio A Scorza
Cited in Scopus: 0We read with interest the article by Kamura et al. about a 57-year-old, previously healthy male patient, who presented with leg pain 2 weeks after the first dose of the Moderna vaccine (Kamura et al., 2022). Four weeks after the vaccination, he was diagnosed with rhabdomyolysis upon the clinical presentation (muscle pain), elevated creatine-kinase (maximal value 74,804 U/l [n, 60-287 U/l]), and the muscle magnetic resonance imaging (MRI) (Kamura et al., 2022). During the following course, the patient additionally developed multiorgan infarctions and, finally, died despite intensive diagnostic and therapeutic approaches (Kamura et al., 2022). - Letter to the EditorOpen Access
The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19
International Journal of Infectious DiseasesVol. 120p44–45Published online: April 11, 2022- Céleo Ramírez
- Reyna M. Durón
Cited in Scopus: 4Dear Editor, - Letter to the EditorOpen Access
Parasites Protect from Severe COVID-19. Myth or Reality?
International Journal of Infectious DiseasesVol. 119p117–118Published online: March 21, 2022- Abdelrahman M Makram
- Marcel Alied
- Zeeshan Ali Khan
- Nguyen Tien Huy
Cited in Scopus: 2During the overheating investigations of factors that can decrease COVID-19 severity, coinfection with some parasitic diseases was identified (Gluchowska et al., 2021). In this letter, we will elaborate why we think that the protective effect of intestinal parasitic coinfection with COVID-19 could be a myth. - LetterOpen Access
Exclude differentials before diagnosing SARS-CoV-2-associated acute haemorrhagic necrotising encephalitis
International Journal of Infectious DiseasesVol. 117p220–221Published online: February 9, 2022- Josef Finsterer
- Daniel Matovu
Cited in Scopus: 0We eagerly read the article by Mierzewska-Schmidt et al., about a 2-month-old boy who developed progressive neurological compromise (initially irritability, apathia, nystagmus) 2 days after the clinical onset of COVID-19 (Mierzewska-Schmidt et al., 2021). On cerebrospinal fluid (CSF) investigation pleocytosis, lactic acidosis, and low glucose was noted, and cerebral magnetic resonance imaging (MRI) helped diagnose acute, hemorrhaghic, necrotising encephalitis (AHNE) (Mierzewska-Schmidt et al., 2021). - Letter to the EditorOpen Access
The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
International Journal of Infectious DiseasesVol. 117p24Published online: January 31, 2022- Giuseppe Lippi
- Mario Plebani
Cited in Scopus: 2We read with interest the article by Gargouria et al. (Gargouria et al., 2022), which described the cases of 4 patients with recurrent SARS-CoV-2 infection despite “the presence of (anti–SARS-CoV-2 S1 IgG) antibodies.” Although the continuous emergence of new and highly mutated SARS-CoV-2 variants is posing paramount challenges to adaptative immunity (Lippi et al., 2021), the message delivered by the authors is not supported by data and is thus potentially misleading. - Letter to the EditorOpen Access
Correspondence on “The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings”
International Journal of Infectious DiseasesVol. 117p187–188Published online: January 27, 2022- Liang En Wee
- Edwin Philip Conceicao
- Jean Xiang-Ying Sim
- Indumathi Venkatachalam
- Limin Wijaya
Cited in Scopus: 0We note the interest by Boddeti et al. (Boddeti et al., 2022) in our article that reported the use of rapid-antigen detection (RAD) in screening asymptomatic hospital visitors for SARS-CoV-2 at the point-of-entry during the COVID-19 pandemic (Wee et al., 2022). - LetterOpen Access
Response to “Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database” by Sato et al
International Journal of Infectious DiseasesVol. 116p10Published online: December 23, 2021- John R. O'Fee
- Joy Li
- Jessica R. Chang
Cited in Scopus: 0To the Editor: - LetterOpen Access
Impaired hearing following SARS-CoV-2 vaccinations
International Journal of Infectious DiseasesVol. 115p215–216Published online: December 8, 2021- Josef Finsterer
- Fulvio A Scorza
- Ana C Fiorini
Cited in Scopus: 1We appreciated reading the article by Jeong et al. regarding 3 patients developing sensorineural hearing loss (SNHL) 3−16 days after the second Astra Zeneca vaccine (case-1), and after the first (case-2) and second Pfizer vaccine (case-3) (Table 1) [Jeong et al. 2021]. Only 2 patients benefited from steroids. In case-3, SNHL deteriorated under treatment [Jeong et al. 2021]. The study is appealing but raises concerns. - Letter to the EditorOpen Access
A five-day course of ivermectin may reduce the duration of COVID-19 illness
International Journal of Infectious DiseasesVol. 110p93–94Published online: July 25, 2021- Sabeena Ahmed
- Wasif Ali Khan
Cited in Scopus: 1We would like to thank you for sending us the letter from Dr Ajay Kumar Shukla and Dr Saurav Misra relating to our article entitled ‘A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness’, published in the International Journal of Infectious Diseases (Ahmed et al., 2021). - Letter to the EditorOpen Access
The potential significance of vitamin D binding protein polymorphism in COVID-19
International Journal of Infectious DiseasesVol. 109p90Published online: June 23, 2021- Marijn M Speeckaert
- Joris R. Delanghe
Cited in Scopus: 3With interest, we read the paper by Nasiri al. (Nasiri et al., 2021), which investigated the relationship between vitamin D and the prognosis in Coronavirus Disease 2019 (COVID-19) patients. A significant association between the hospital stay and lower serum vitamin D levels was demonstrated. Although several confounders were taken into account, we would like to focus on the potential important influence of vitamin D binding protein (DBP) polymorphisms on the reported results. - Letter to the EditorOpen Access
Why are COVID-19 fatality rates among medical doctors higher than those among medical nurses?
International Journal of Infectious DiseasesVol. 104p592–593Published online: January 29, 2021- Deepak Gupta
Cited in Scopus: 0Erdem’s and Lucey’s callout to the World Health Organization about reporting COVID-19 morbidity/mortality data of global healthcare workers is commendable (Erdem and Lucey, 2020). However, being designed as a survey, their data table may lead to some misinterpretations. For example, as compared with COVID-19 morbidity/mortality among medical doctors, their data reported more numbers of COVID-19 infections and yet less COVID-19 fatality rates among medical nurses in eight of the 18 surveyed countries that have reported at least 50 COVID-19 infections among medical doctors and nurses (i.e., Bangladesh, Bulgaria, Colombia, Croatia, Czech Republic, Egypt, France, India, Iran, Italy, Kosovo, Lebanon, Mexico, Oman, Pakistan, Poland, Portugal, and Romania).
